Lv6
2190 积分 2021-12-13 加入
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
3天前
已完结
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma
3天前
已完结
Endoscopic Ultrasound‐Guided Brachytherapy of Yttrium‐90 Implantation Into Pancreas: A Dose‐Escalation Pilot Study
8天前
已完结
Loss of both diffusion restriction and arterial enhancement can predict complete pathological response following Y-90 selective internal radiation therapy for hepatocellular carcinoma
1个月前
已完结
Efficacy and evaluation of dose-response relationship of selective internal radiation therapy for the management of liver metastases in neuroendocrine neoplasia
1个月前
已完结
Safety and feasibility of Y90 radioembolization for cirrhosis-induced splenomegaly and thrombocytopenia: results from an investigational device exemption study
1个月前
已关闭
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients
1个月前
已完结
Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization
1个月前
已完结
Radioactive Yttrium 90: A review of its properties, biological behavior, and clinical uses
1个月前
已完结
Harnessing yttrium-90 selective internal radiation therapy for primary hepatocellular carcinoma: Mechanisms of action and combination strategies
1个月前
已关闭
皖公网安备34019202002308
